MentionFox
Home › Executive changes › Biogen Inc.
Leadership changes · BIIB · SEC Form 8-K, Item 5.02

Leadership changes at Biogen Inc. (2026)

Before you join, sell to or invest in Biogen Inc.

MentionFox check on Biogen Inc.: only 2 sources on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/biogen

Check Biogen Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Biogen Inc.?

Who joined and who left Biogen Inc. (BIIB)? 1 departure reported from 2026-02-11 to 2026-03-11, each cited to the company's own filing.

Susan H. Alexander's departure as Chief Legal Officer of Biogen Inc. was reported; the filing names no successor. As of November 15, 2026, Biogen Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from February 11, 2026 to March 11, 2026, naming 1 departure (Form 8-K, March 11, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

PRIMECAP MANAGEMENT CO/CA/ also filed stake reports on 24 other companies ↓

Sell to companies like Biogen Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes2
Out (departing)1
Latest filing2026-03-11

Biogen Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-02-11 to 2026-03-11. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Biogen Inc. files it.

Also on the record for Biogen Inc.

DateRecordFigureOur pageSource
November 10, 2026Stake report, Schedule 13G, by STATE STREET CORPORATION5.1% of the class5%+ stakesSource
August 6, 2026Stake report, Schedule 13G/A, by FMR LLC12.4% of the class5%+ stakesSource
June 5, 2026Stake report, Schedule 13G/A, by FMR LLC11.3% of the class5%+ stakesSource
May 6, 2026Stake report, Schedule 13G/A, by FMR LLC8.7% of the class5%+ stakesSource
April 29, 2026Stake report, Schedule 13G, by Vanguard Capital Management7.48% of the class5%+ stakesSource
March 26, 2026Stake report, Schedule 13G/A, by The Vanguard Group—5%+ stakesSource
February 5, 2026Stake report, Schedule 13G, by FMR LLC6.4% of the class5%+ stakesSource
November 13, 2025Stake report, Schedule 13G/A, by PRIMECAP MANAGEMENT CO/CA/10.2% of the class5%+ stakesSource
November 10, 2025Stake report, Schedule 13G, by STATE STREET CORPORATION5% of the class5%+ stakesSource

Selling to them or working with them? See who runs Biogen Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Biogen Inc. and the records around it.

Biogen Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on Biogen Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Biogen Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Biogen Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    11 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-03-11OutChief Legal Officer8-K, 2026-03-11
2026-02-11Reportednot named in the filing8-K, 2026-02-11

Why did they leave? What the filings say

Biogen Inc.'s filings state no reason for the departures below. Where a filing gives none, it says so here; nothing is inferred.

Who leads Biogen Inc., as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to Biogen Inc.?

New leaders reset buying decisions — get the Full Report on Biogen Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Biogen Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the Chief Legal Officer at Biogen Inc., with the record behind each one.

Find candidates like Chief Legal Officer at Biogen Inc.

Every change, in the filing's words

Filed 2026-03-11 · 8-K

Departing: Susan H. Alexander, Chief Legal Officer

On March 11, 2026, Biogen Inc. (the "Company") announced that Susan H. Alexander, Chief Legal Officer, will depart from the Company effective as of the end May, 2026.

Also stated in this filing

  • The Company has initiated a search to identify the Company's next Chief Legal Officer.
Filed 2026-02-11 · 8-K

Reported

On February 11, 2026, Caroline Dorsa, Chair of the Biogen Inc. ("Biogen" or the "Company") Board of Directors (the "Board") announced that she would not stand for re-election to the Board at the 2026 Annual Meeting of Stockholders (the "Annual Meeting").

Also stated in this filing

  • Ms. Dorsa's decision to not stand for reelection was not related to any disagreement with the Board or the Company on any matter relating to its operations, policies or practices.

Tools for this story

Each opens in a new tab, filled in for Biogen Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/biogen
Last updated 2026-11-15
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Biogen Inc. executive departure 2026. MentionFox, 2026-11-15. https://mentionfox.com/executive-changes/biogen